Intronix Technologies Blog
Myoguide ™ Injection Site Targeting System Earns CE Mark
Myoguide poised to become essential pain and spasticity treatment tool in hands of European physicians We are extremely pleased to have obtained CE Mark approval for Myoguide. Clinicians throughout the European Union may now treat their patients suffering from acute and chronic pain, and spasticity with a highly portable electromyographic (EMG) precision device from Intronix…
European Pain Survey Yields Stunning Conclusions
“Chronic pain of moderate to severe intensity occurs in 19% of adult Europeans, seriously affecting the quality of their social and working lives. Very few were managed by pain specialists and nearly half received inadequate pain management. Although differences were observed between the 16 countries, we have documented that chronic pain is a major health…
A Conversation with Dr. Chan Gunn
I’d like to include an excerpt from an interchange with Dr. Chan Gunn. Of course, you should check out his website: www.istop.org . He’s a brilliant pain management physician. I must say that his work has influenced our direction early on in our research and development program. This excerpt leads to his assessment of Myoguide’s…
Updated Website is LIVE
We’ve just launched our new and improved website. We will be updating as often as we have new things to say, new products to launch, and new events to attend. Check us out, its a great new website. It loads faster, easily accesses content and there is lots of content to browse. www.intronixtech.com
Intronix invited to present at OCE Discovery
Intronix was invited to present Myoguide at the Ontario Center of Excellence “Discovery 2011”, at the Metro Toronto Convention Centre on May 18th. The invitation came courtesy of the Research Innovation and Commercialization Centre. We appreciate the opportunity to present our technology to the medical device and VC community. Feel free to come on by…
Back from the Mayo Clinic
We were very pleased to take part in the Mayo Clinic lecture series held at Amelia Island. The topics covered Electromyography, Electroencephalography, and Neurophysiologyin Clinical Practice. This is part of our continuing commitment to continuing education and keeping up to date in areas we have chosen to work in. We thank the Mayo Clinic for…
Myoguide is ready for sale in CANADA
After several years of testing Myoguide in the clinics for reliability, features, and ergonomics, We are pleased to make Myoguide available for sale in Canada.
New Myoguide Clinical Videos Posted!
We have posted more clinical videos on the Myoguide product page: https://www.intronixtech.com/Myoguide%20System.htm One clinical session shows a Piriformis Muscle injection and another shows another E-Stim, or Stimulation Location injection. We’ll continue to add to our online library for demonstrations purposes only. We do not intend to use these videos to instruct anyone on how to…
Myoguide Achieves TüV Certification Mark
We are pleased to announce that we have received our TüV certification mark for Myoguide. Intronix Technologies’ commitment to quality assurance continues. Intronix worked with TüV SUD to certify compliance to all the IEC requirements to ensure safety for Myoguide.
MEDICA 2011
Intronix will be returning to MEDICA, with Myoguide, in Düsseldorf, Germany: Hall 16, November 16-19, 2011. We are proud to have been selected to exhibit within the CANADA Pavilion, for the third time.